GKOSのROE（自己資本利益率）は？

GLAUKOS CORPのROEは-27.55%です。

GKOSの配当利回りは？

GLAUKOS CORPの配当利回りは0.00%です。

GKOSの品質スコア（Quality Score）は？

当社のAIはGKOSの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

GKOSは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

GKOSはどのセクターに属しますか？

GLAUKOS CORPはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）

GKOS (NYSE) 株価分析 | GLAUKOS CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

GKOS AI Analysis Summary

Our AI summary for GKOS: GLAUKOS CORP (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -27.55%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

GKOS

GLAUKOS CORP

US:NYSE STOCK Healthcare >> Medical Devices

USD 166.72

-1.80 (-1.07%) Day Change

Watchlist Portfolio Compare Chart

0.35

D/E

-27.6%

ROE

-20.4%

ROA

0.00%

Div Yield

GLAUKOS CORP
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 166.72 Price -1.80 (-1.07%) Day Change	NEWS SCORE: N/A

GKOS, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	166.72
PBV / Sector	14.56 / -101.57
Earning Per Share	-3.15

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	137.66 M GREAT
Average 1W Daily Value	278.88 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-30.68 / 20.50
NPM Average (%) / Sector	-36.74 / -15.37
NPM Change Average (%) / Sector	-2.23 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-20.43 / 39.11
ROA Average (%) / Sector	-16.00 / 5.58
ROA Change Average (%) / Sector	24.27 / 104.50 GREAT
ROE (%) / Sector	-27.55 / -166.42
ROE Average (%) / Sector	-24.62 / -16.93
ROE Change Average (%) / Sector	16.87 / -500.08 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

登録情報

Analyze Date	2026-08-01 07:59:54
Symbol	GKOS
Name	GLAUKOS CORP
Sector	Healthcare >> Medical Devices
Market	NYSE
Listed Shares	58.98 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	9,939.97 / 20,104.97

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: One Glaukos Way, Aliso Viejo, CA, United States, 92656

Phone: 949 367 9600

Website: https://www.glaukos.com

Employees: 1,094

Sector: Healthcare >> Medical Devices

Description: Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.